MTOR and prostate carcinoma: This laboratory evidence shows that Tanshinone can inhibit mTOR-mediated tumor malignant behavior in prostate cancer cells by regulating the expression and phosphorylation of upstream and downstream protein molecules of the mTOR-mediated signaling pathway or by regulating other molecular pathways with obvious crosstalk with mTOR.